| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
34,790 |
31,508 |
$1.44M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
17,619 |
17,522 |
$1.24M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,466 |
16,239 |
$508K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
9,171 |
9,130 |
$495K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,772 |
4,436 |
$99K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,730 |
2,612 |
$49K |
| 99215 |
Prolong outpt/office vis |
537 |
517 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,013 |
1,497 |
$22K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,573 |
1,441 |
$21K |
| S9083 |
Global fee urgent care centers |
281 |
260 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,492 |
3,452 |
$19K |
| 99401 |
|
1,329 |
1,249 |
$18K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
474 |
470 |
$18K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,059 |
999 |
$16K |
| 99385 |
|
96 |
96 |
$10K |
| 81003 |
|
4,798 |
4,651 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
217 |
216 |
$8K |
| 93000 |
|
227 |
226 |
$7K |
| 99205 |
Prolong outpt/office vis |
64 |
64 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
409 |
390 |
$4K |
| 99386 |
|
60 |
60 |
$4K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
667 |
600 |
$3K |
| 99051 |
|
1,593 |
1,528 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
114 |
113 |
$2K |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
224 |
211 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
102 |
102 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
139 |
138 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
45 |
45 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$996.32 |
| 99000 |
|
298 |
292 |
$946.15 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
16 |
$779.92 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
26 |
25 |
$373.91 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
27 |
27 |
$330.60 |
| 81025 |
|
95 |
95 |
$223.88 |
| 82962 |
|
78 |
76 |
$186.40 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
12 |
12 |
$182.46 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
27 |
25 |
$112.03 |
| 86580 |
|
21 |
18 |
$47.04 |
| 94760 |
|
322 |
306 |
$44.90 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
203 |
198 |
$40.50 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
115 |
109 |
$12.53 |
| A9150 |
Non-prescription drugs |
12 |
12 |
$0.00 |